Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.74 USD | +0.68% | -1.02% | -11.17% |
Apr. 16 | QIAGEN NV : Deutsche Bank reiterates its Buy rating | ZD |
Apr. 03 | Qiagen N.V. Strengthens Its Portfolio for Cancer Research, Showcases Latest Product Launches At AACR Annual Meeting 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.17% | 8.74B | |
-1.15% | 41.35B | |
+42.61% | 40.38B | |
+3.59% | 39.05B | |
-12.11% | 26.67B | |
+2.71% | 24.07B | |
-23.73% | 18.36B | |
-3.40% | 11.68B | |
+22.43% | 11.6B | |
+7.67% | 11.15B |
- Stock Market
- Equities
- QGEN Stock
- News Qiagen N.V.
- Transcript : Qiagen N.V. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 10